Evidence map›Paper›PMID 31747390›Full record

ArticlePLoS genetics2019

East-Asian Helicobacter pylori strains synthesize heptan-deficient lipopolysaccharide.

Hong Li, Michael Marceau, Tiandi Yang, Tingting Liao, Xiaoqiong Tang, Renwei Hu, Yan Xie, Hong Tang, Alfred Tay, Ying Shi and 13 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Frontiers in cellular and infection microbiology · 2024
    Article
  7. Article
  8. Article
  9. Roles of Lipopolysaccharide Glycosyltransferases in Maintenance ofInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. International journal of molecular sciences · 2022
    Review
  12. Article
  13. The Effects ofBiomedicines · 2022
    Article
  14. Frontiers in immunology · 2022
    Review
  15. Article
  16. Riboregulation in the Major Gastric PathogenFrontiers in microbiology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 4 countries.

Hong LiWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Michael MarceauUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-CIIL-Center for Infection and Immunity of Lille, Lille, France.ORCID 0000-0002-4403-8081
Tiandi YangDepartment of Life Sciences, Imperial College London, South Kensington Campus, London, United Kingdom.ORCID 0000-0002-6634-0847
Tingting LiaoHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.
Xiaoqiong TangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Renwei HuDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Yan XieDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Hong TangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-9790-6225
Alfred TayHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.ORCID 0000-0001-9705-4010
Ying ShiWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yalin ShenWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Tiankuo YangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Xuenan PiPrecision Medicine Key Laboratory of Sichuan Province & Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-1631-8278
Binit LamichhaneHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.ORCID 0000-0002-5808-8274
Yong LuoKey Laboratory of Geoscience Spatial Information Technology, Ministry of Land and Resources of the P.R.China, Chengdu University of Technology.
Aleksandra W DebowskiHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.ORCID 0000-0002-9105-3989
Hans-Olof NilssonHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.
Stuart M HaslamDepartment of Life Sciences, Imperial College London, South Kensington Campus, London, United Kingdom.ORCID 0000-0002-5563-679X
Barbara MulloyDepartment of Life Sciences, Imperial College London, South Kensington Campus, London, United Kingdom.
Anne DellDepartment of Life Sciences, Imperial College London, South Kensington Campus, London, United Kingdom.
Keith A StubbsSchool of Molecular Sciences, University of Western Australia, Crawley, Australia.
Barry J MarshallHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Australia.
Mohammed BenghezalWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-4207-0192
Sichuan University · CNThe University of Western Australia · AUImperial College London · GBCentre National de la Recherche Scientifique · FRMinistry of Natural Resources · CN

Funding

Biotechnology and Biological Sciences Research Council BB/K016164/1
6 · The paper itself

Abstract

The lipopolysaccharide O-antigen structure expressed by the European Helicobacter pylori model strain G27 encompasses a trisaccharide, an intervening glucan-heptan and distal Lewis antigens that promote immune escape. However, several gaps still remain in the corresponding biosynthetic pathway. Here, systematic mutagenesis of glycosyltransferase genes in G27 combined with lipopolysaccharide structural analysis, uncovered HP0102 as the trisaccharide fucosyltransferase, HP1283 as the heptan transferase, and HP1578 as the GlcNAc transferase that initiates the synthesis of Lewis antigens onto the heptan motif. Comparative genomic analysis of G27 lipopolysaccharide biosynthetic genes in strains of different ethnic origin revealed that East-Asian strains lack the HP1283/HP1578 genes but contain an additional copy of HP1105 and JHP0562. Further correlation of different lipopolysaccharide structures with corresponding gene contents led us to propose that the second copy of HP1105 and the JHP0562 may function as the GlcNAc and Gal transferase, respectively, to initiate synthesis of the Lewis antigen onto the Glc-Trio-Core in East-Asian strains lacking the HP1283/HP1578 genes. In view of the high gastric cancer rate in East Asia, the absence of the HP1283/HP1578 genes in East-Asian H. pylori strains warrants future studies addressing the role of the lipopolysaccharide heptan in pathogenesis.

Indexed as

Asian PeopleFucosyltransferasesGlucansGlycosyltransferasesHelicobacter InfectionsHelicobacter pyloriHumansLewis Blood Group AntigensLipopolysaccharidesMutagenesisO AntigensStomach NeoplasmsFucosyltransferasesGlucansGlycosyltransferasesLewis Blood Group AntigensLipopolysaccharidesO Antigens

Identifiers

PMID31747390
PMCPMC6892558
OpenAlexW2991459893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.